NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 1.23% |
UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.04% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 1.02% |
INSM | Insmed Inc | Healthcare | Biotechnology | 1.01% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.00% |
IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 0.98% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 0.97% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 0.96% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 0.96% |
EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 0.95% |
EXEL | Exelixis Inc | Healthcare | Biotechnology | 0.95% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 0.95% |
RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 0.94% |
ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 0.94% |
BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 0.93% |
MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 0.92% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 0.92% |
RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 0.92% |